Prevalence of Toxoplasma gondii, Cytomegalovirus and Rubella virus among aborted women in Samarra city

Main Article Content

Sinai Najy Muhsin AL-doury

Abstract

The aim of this study is to determine seroprevalence of Toxoplasma gondii, CMV and Rubella virus for 158 aborted women in Samarra General Hospital through period from January to December 2016. The prevalence of T. gondii was 14.6%, CMV 10.8%, Rubella virus 8.2% and common Toxo. & CMV was 9.5%. Also, the present  study showed that infection with each of T. gondii, CMV and Rubella were highest (24.2%, 15.2%, 15.2% respectively) in age group 21-30 years old, while common infection with Toxo. & CMV was highest 11.8% in age group 14-20 years old. The  seroprevalence  results were for anti-Toxo. IgM was 7%, IgG was 3.2%,  and  IgM & IgG was 4.4%, anti-CMV IgM was 5.7%, IgG was 1.9%, and IgG & IgM was 3.2% and anti-Rubella IgM 3.8%, IgG 1.9%, and IgG & IgM was 2.5%. While the seroprevalence  of  both  Toxo. & CMV was anti-Toxo. IgG & anti-CMV IgM was 0.63%, anti-Toxo. IgM & anti-CMV IgM was 2.5%, anti-Toxo. IgG & anti-CMV IgG & IgM was 1.9%, anti-Toxo. IgM & anti-CMV IgG & IgM was 3.2% and anti - Toxo. IgM & anti-CMV IgG was 1.3%.

Article Details

How to Cite
Sinai Najy Muhsin AL-doury. (2023). Prevalence of Toxoplasma gondii, Cytomegalovirus and Rubella virus among aborted women in Samarra city. Tikrit Journal of Pure Science, 23(7), 32–35. https://doi.org/10.25130/tjps.v23i7.692
Section
Articles

References

1- Stuart G and Grimes DA. (2010) Terminology of abortion. J. Contra., 81 (2) pp.6- 93.

2- Khalida AI, Maysara SK and Dhammra WA. (2012) the seroprevalence study of cytomegalovirus between infected aborted women. J. The Iraqi postgradu. Med., 11(1) pp. 123.

3- Zuhara KF, Sekaran K and Sebastian D. (2008) effect of TORCH in first trimestermiscarriage in the Malabar Kerala. African J. Microbio. Res., 2 pp. 56-59.

4- Aggarwal A, Chopra S and Arora U. (2004) Prevalence of IgM to Toxoplasma, Rubella and Cy-tomegalovirus Infections. J. K. scien., 6 (4) pp.190-192.

5- Koliou M, Detsika M, Sifakis S, Antoniou M and Messaritakis I. (2008) study of Geno-types of Toxoplasmosis in Pregnant Women & Patients from Crete and Cyprus. Americ. Socie. Of Tropic. Medic. And Hyg., 79(2) pp. 205-209.

6- Les TJ, Rosso F, Villalobos C, Chaves AJ, Agudelo A, Messa A, Remington SJ, Tunubala AG and Montoya GJ. (2008) Prevalence of

Toxoplasmosis between Pregnant Women in Ca-li,ColombiaSouth America. Americ. Soci. Of Trop. Medi. And Hyg., 78(3) pp. 504-508.

7- Demmler GJ. (1991) Infectious diseases society of America and centers for disease control: Summary of a workshop on surveillance for congenital cytomegalovirus disease. Rev. Infect. Dis., 13(3) pp.15-29.

8- Abdul-Muhymen N, Al-Saadie M and Abdul-Karim ET. (2009) Chlamydia & rubella antibodies in women with full-term deliveries and women with abortion in Baghdad. East. Medi. Heal. J., 15 (6) pp. 1407-1411.

9- Al-Jebouri M, Al-Janabi M and Ismail H. (2013) The prevalence of toxoplasmosis among female patients in Al-Hawija and Al-Baiji Districts in Iraq. Open J. of Epidemio., 3 pp. 85-88.

10-AL- kalaby RF, AL-Fatlawi SN and Sultan BA. (2016) Relationship between abortion & Toxo. gondii in aborted women in Najaf province.Scien. J. of Kerbala Univ., 14 (1) pp. 177-185.

11-Jasim M, Ali AI and Majeed HA. (2011) serological diagnosis of TORCH in both aborted and non aborted women in waste. Tik. Med. J., 17(2) pp. 141-147.

12- AL-Hindawi N Gh and AL-Shanawi FA. (2015) roprevalence of CMV, Toxo. gondii in aborted women in BaghdadIraq. Iraqi J. of sciences., 56(1) pp.694-655.

13- Meral T, Aysun K, Yusuf P, and Yasemin IB (2011) Evaluation of, T. gondii , cytomegalovirus & rubella seroprevalences between pregnant women in Denizli. Turk. J. Med. Sci, 41 (1) pp. 159-164.

14- Vauloup-Fellous C, Picone O, Parent CI, Senat MV, Frydman R and Cordier AG.(2009) A two-years study on CMV infection during pregnancy in a French hospital. BJOG., 116 PP. 818-823.

15- Robson J, Coulter C and Wood R. (1999) Rubella in pregnancy. Commu. Disea. Intell. J., 23 pp. 93–96.

16-Sadik MS, Jamil K, Patil C and Fatima H. (2012) TORCH study in patients with bad obstetric history. Bio.& Med.J., 4 (2) pp. 95-101.

17- Hadi NJ.(2011) Seroprevalence of CMV, Toxo. gondii & Rubella virus between aborted women in Thiqar. J. of college of education for pure science., 5(1) pp.3-9.

18- Hassan HMM, AL-Samarai AM, AL-Jumaili ZKM and AL-Obaidi AH. (2014) Association between CMV & bad obstetric outcomes in women at Kirkuk. Internation. J. of Publ. Heal. Science., 3(1) pp.29-42.

19- AL-Shimmery MN, AL-Khafaji AA and AL-Hilaly HA. (2011) Seroprevalence of CMV & Toxo. gondii in aborted women in AL-Diwaniyah province. Q.M.J., 7(11) pp.160-166.

20- Mumtaz C. Neval MD, Sirin MD, Nisel MD, Yeser K, Derici MD, Arzu MD. (2017) Seroprevalence of T. gondii, Rubella virus and CMV in pregnant women and the

avidity assays importance. Saudi. Med. J., 38 (7) pp.727-732.

21- Karabulut A, Türk M, Polat Y and Işık Balcı Y. (2011) Evaluation of Rubella, T. gondii and CMV seroprevalence between pregnant women in Denizli. Turk. Med. Sci. J., 41 PP. 159-164.

22- Cim N, Erdin BN, Pariak M, Guven A and Bayram Y. (2015) seroprevalence of T. gondii, Rubella & CMV in pregnant women in Van. Obset. Gynecol. Turk. J., 12(2) PP. 79-82.

23- Naouri B, Bekhit R, Ahmed H, Mohsni E, Teleb N. (2011) Progress Toward Measles Elimination in the Eastern Mediterranean Region. Infect. Dis. J., 204(l 1) PP. 289-298.

24- Majeed HM, Alsamarai AM, Alsalihi FG, Alobaidi AH and Aljumaili ZKM. (2016) Seroprevalence of Rubella among Women with BOH. Immuno. Virol. J.,1(2) PP. 5-7.

25- Karad D and Kharat A . (2015) Seroprevalence of Torch in Bad Obstetrics History among HIV and Non-HIV Women in Solapur of Maharashtra India. Hum. Virol. Retrovirol. J., 2 pp. 67.